Related Experiment Video
Updated: Aug 18, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
New and emerging pediatric infections
1Department of Dermatology, Texas Children's Hospital, Baylor College of Medicine, 6621 Fannin Street, CC 620.16 6560, Houston, TX 77030-2399, USA. dwmetry@bcm.tmc.edu
Abstract:
Several aspects of emerging pediatric cutaneous infections are of importance to the clinician. New manifestations of parvovirus infection should be recognized promptly, especially because transmission to susceptible populations might lead to serious complications. In the immunocompromised pediatric population, the outcome of cutaneous mold infections can be improved with prompt recognition and initiation of treatment. The incidence of community-acquired MRSA infections in pediatrics is becoming more than a regional concern, and this coincides with the issue of limited antibiotic susceptibility for MRSA as well as other infections. New antibiotics such as linezolid are emerging as potential treatments for drug-resistant pathogens. An older group of antibiotics, the fluoroquinolones, appear to be well tolerated in children and should not be withheld from this population when the benefits of treatment out-weigh the risks.
Insights
Prompt recognition of new pediatric skin infections, including parvovirus and mold, is crucial. Emerging antibiotic resistance, particularly community-acquired MRSA, necessitates exploring new treatments like linezolid and considering fluoroquinolones for children.
Area of Science:
- Pediatric Dermatology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Emerging pediatric cutaneous infections pose clinical challenges.
- New parvovirus manifestations require prompt recognition to prevent complications in susceptible populations.
- Cutaneous mold infections in immunocompromised children necessitate early diagnosis and treatment for better outcomes.
Purpose of the Study:
- To highlight key emerging pediatric skin infections.
- To discuss the implications of increasing community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) in children.
- To review potential therapeutic options for drug-resistant pediatric infections.
Main Methods:
- Literature review of recent advancements in pediatric dermatology and infectious diseases.
- Analysis of trends in antibiotic susceptibility and resistance patterns.
- Evaluation of novel and established antibiotic classes for pediatric use.
Main Results:
- Parvovirus infections can have serious complications in specific pediatric groups.
- Prompt management of cutaneous mold infections improves outcomes in immunocompromised children.
- Community-acquired MRSA incidence is a growing concern with limited antibiotic options.
Conclusions:
- Early identification of new pediatric skin infection presentations is vital.
- Linezolid shows promise for treating drug-resistant pathogens in children.
- Fluoroquinolones are a viable option for pediatric infections when benefits outweigh risks.
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Sexually Transmitted Infections
Acute Pyelonephritis I: Introduction
Infectious Diseases and Their Occurrence
Pneumonia I: Introduction

